Scarica l'app Stockscreener
8.3831
3.32%
0.2695
Dopo l'orario di chiusura:
8.38
-0.0031
-0.04%
Precedente Chiudi:
$8.1136
Aprire:
$8.31
Volume 24 ore:
2,636
Relative Volume:
0.38
Capitalizzazione di mercato:
$10.93M
Reddito:
$630.00K
Utile/perdita netta:
$5.72M
Rapporto P/E:
-24.55
EPS:
-0.3415
Flusso di cassa netto:
$-6.75M
1 W Prestazione:
-18.03%
1M Prestazione:
+3.37%
6M Prestazione:
+4.79%
1 anno Prestazione:
-3.09%
Intervallo 1D:
$8.31
$8.3831
Intervallo di 1 settimana:
$8.1136
$11.00
Portata 52W:
$6.51
$13.27
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
Nome
Addex Therapeutics Ltd Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta ADXN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd Adr
|
8.3831 | 10.93M | 630.00K | 5.72M | -6.75M | -0.3415 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-31 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr Borsa (ADXN) Ultime notizie
European Equities See Growth In US ADR Market - Finimize
Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference - GlobeNewswire Inc.
Addex Raises $10.0 Million In Equity Financing - Barchart.com
Addex Therapeutics Earnings Call: Strategic Gains Amid Financial Challenges - TipRanks
Addex Therapeutics Reports Strong 2024 Financial Turnaround - TipRanks
META_TITLE_SECTORS - Yahoo Finance
Coincheck Group N.V (CNCK) produces promising results - US Post News
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Yahoo Finance
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance
Drug discovery and bringing new medicine to marketthe future of AI in pharma - OutSourcing-Pharma.com
What Makes Addex Therapeutics (ADXN) a New Buy Stock - Nasdaq
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
LYRA Stock Quote Price and Forecast - CNN
Esperion Therapeutics (ESPR) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq
Addex Therapeutics (ADXN) Stock Rallied 62.1% on Phase 2 Study - AskTraders.com
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Addex (ADXN) Terminates Parkinson's-Related Dyskinesia Study - Nasdaq
Addex To Present At The H.C. Wainwright BIOCONNECT Virtual Conference - Barchart.com
Addex Reports Q3 2021 Financial Results And Provides Corporate Update - Barchart.com
ADXN Stock Price and Chart — SIX:ADXN - TradingView
Addex Therapeutics Ltd Adr Azioni (ADXN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.91%
1.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):